1 / 21

GH.NADERIAN, MD

GH.NADERIAN, MD. GH.NADERIAN MD. Chloroquine maculopathy Chloroquine ( CQ) Hydroxychloroquine (HCQ). The first reports concerned long term use of CQ for malaria and later reports showed retinopathy after treatment of anti- inflammatory disease. GH.NADERIAN, MD.

alexis-guerrero
Download Presentation

GH.NADERIAN, MD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. GH.NADERIAN, MD

  2. GH.NADERIAN MD

  3. Chloroquine maculopathy Chloroquine ( CQ) Hydroxychloroquine (HCQ)

  4. The first reports concerned long term use of CQ for malaria and later reports showed retinopathy after treatment of anti- inflammatory disease GH.NADERIAN, MD

  5. The mechanism of CQ and HCQ toxicity is not well understood Acute effects on the metabolism of retinal cells Bind to melanin in the RPE

  6. The clinical picture of CQ and HCQtoxicity is characterized classically by bilateral bulls eye GH.NADERIAN, MD

  7. Factors increasing the risk of CQ and HCQ retinopathy: GH.NADERIAN, MD

  8. Duration Duration of use >5 years GH.NADERIAN, MD

  9. Cumulative dose HCQ > 1000 gr (total) CQ > 460 gr (total) GH.NADERIAN, MD

  10. Daily dose HCQ > 400 mg / day CQ > 250 mg / day GH.NADERIAN, MD

  11. Age Age : Elderly GH.NADERIAN, MD

  12. Systemic disease : kidney or liver dysfunction GH.NADERIAN, MD

  13. Ocular disease : retinal disease or maculopaty GH.NADERIAN, MD

  14. Genetic factors ?? GH.NADERIAN, MD

  15. American Academy Of Ophthalmology (feb 2011) Recommendations on screening for CQ and HCQ retinopathy GH.NADERIAN, MD

  16. Time line Base line examination within first year of use Annual screening after 5 years of use GH.NADERIAN, MD

  17. Recommended screenig procedures Ocular examination Automated visual field GH.NADERIAN, MD

  18. In addition , if available , perform one or more of the following objective tests SD - OCT mf ERG FAF (fundus auto fluroscence)

  19. Not recommended for screening Fundus photography Time –domain OCT FA Amsler grid Color testing EOG

  20. Thanks for your attention

More Related